India is seeking a larger role in multinational clinical research, and the argument is increasingly about more than cost. In a recent interview with Pharma Industrial India, Dr. Seema Pai, President of the Indian Society for Clinical Research (ISCR), described India’s growing ambitions in global clinical trials. Her comments focused...
India Streamlines Regulations for Clinical Research
With the aim of creating a conducive environment that fosters research and new drug development in India, the government has amended some critical clauses and framed new guidelines that are aligned to global regulations. In an interview with BioSpectrum Asia Magazine, Suneela Thatte, president, Indian Society for Clinical Research said...